title: Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation.
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Salhotra
authors.affiliation: Department of Biostatistics, City of Hope, Duarte, CA, USA.
authors.forename: N
authors.initials: N
authors.lastname: Tsai
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Thomas
authors.affiliation: Department of Biostatistics, City of Hope, Duarte, CA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Paris
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: P
authors.initials: P
authors.lastname: Parker
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Forman
authors.affiliation: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Nakamura
mesh_terms: D000293:Adolescent; D000328:Adult; D064591:Allografts; D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D012189:Retrospective Studies; D045743:Scleroderma, Diffuse / Q000188:drug therapy* / Q000209:etiology
chemical_list: D047428:Protein Kinase Inhibitors